FDA commits to high safety standards in coronavirus vaccine review

Published



The Food and Drug Administration’s coronavirus vaccine advisory panel assured the public that the approval process will uphold the highest safety standards to boost confidence.

“Only those vaccines that are demonstrated to be safe and effective” will be licensed by the FDA, said Marion Gruber, director of the FDA’s Office of Vaccines Research and Review.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.